24 Hrs
المصدر:
Financial Times
Financial Times
جاهز للتشغيل
جاهز للتشغيل
Biotech stocks surged nearly threefold after a biotech company's mRNA cancer treatment demonstrated promising results. The company, which had faced difficulties in recent years, experienced renewed investor confidence due to the positive developments. The breakthrough suggests potential for the company's cancer therapy in upcoming clinical applications.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading